ORPHAN DRUGS IN FRANCE: KEY MARKET ACCESS INCENTIVES

被引：0
|
作者：
Mennezein, L. [1 ]
Avot, D. [1 ]
Laigle, V [2 ]
机构：
[1] MSD France, Courbevoie, France
[2] MSD Vaccins, Lyon, France
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.943
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY116
引用
收藏
页码：A565 / A565
页数：1
相关论文
共 50 条
  • [21] ORPHAN DRUGS FACE TOUGHER SCRUTINY IN SECURING FAVORABLE PRICING AND MARKET ACCESS
    Grosvenor, A.
    Saraf, S.
    Jones, K.
    VALUE IN HEALTH, 2011, 14 (03) : A22 - A22
  • [22] TIME TO MARKET ACCESS FOR INNOVATIVE DRUGS IN THE UK, FRANCE, AND BELGIUM
    Maervoet, J.
    Toumi, M.
    VALUE IN HEALTH, 2012, 15 (07) : A312 - A312
  • [23] MARKET ACCESS OF DRUGS IN FRANCE AND MEDICO-ECONOMIC ASSESSMENT
    Remuzat, C.
    Toumi, M.
    Aballea, S.
    VALUE IN HEALTH, 2012, 15 (07) : A312 - A312
  • [24] Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients' health needs?
    Rodriguez-Monguio, R.
    Spargo, T.
    Seoane-Vazquez, E.
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [25] Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients’ health needs?
    R. Rodriguez-Monguio
    T. Spargo
    E. Seoane-Vazquez
    Orphanet Journal of Rare Diseases, 12
  • [26] Mechanism of coordinated access to orphan drugs
    R DeRidder
    C Adriaens
    D Kleinermans
    M Mortier
    A Quanten
    F Arickx
    Orphanet Journal of Rare Diseases, 7 (Suppl 2)
  • [27] MECHANISM OF COORDINATED ACCESS TO ORPHAN DRUGS
    DeRidder, H.
    Arickx, F.
    Adriaens, C.
    Quanten, A.
    Mortier, M.
    Kleinermans, D.
    VALUE IN HEALTH, 2013, 16 (07) : A490 - A490
  • [28] PRICING AND MARKET ACCESS OF ORPHAN DRUGS IN ASIA: A COMPARATIVE STUDY ACROSS GROWTH MARKETS
    Sherwin, G.
    Akpinar, P.
    Saraf, S.
    Li, X.
    VALUE IN HEALTH, 2014, 17 (07) : A785 - A785
  • [29] TITLE: ACCESS TO ORPHAN AND ULTRA-ORPHAN DRUGS IN CHINA
    Gambari, J.
    Yang, M.
    Chowdhury, C. A.
    Duttagupta, S.
    VALUE IN HEALTH, 2016, 19 (07) : A826 - A826
  • [30] Analysis of patient access to orphan drugs in Turkey
    Güvenç Koçkaya
    Sibel Atalay
    Gülpembe Oğuzhan
    Mustafa Kurnaz
    Selin Ökçün
    Çiğdem Sar Gedik
    Mete Şaylan
    Nazlı Şencan
    Orphanet Journal of Rare Diseases, 16
12345